Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Prostate Cancer / March 2008

Tip: Looking for answers? Try searching our database.

Blocking Protein Kills cancer cells

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
ronju99 - 04 Mar 2008 23:18 GMT
And if the hot peppers don't work, researchers at Kimmel Cancer center in
Philadelphia have shown they can kill cancer cells by blocking a signaling
protein that is key to the cancers growth called
Stat5.http://www.sciencedaily.com/releases/2008/02/080228080532.htm

Ron S.

--
Message posted using http://www.talkaboutsupport.com/group/alt.support.cancer.prostate/
More information at http://www.talkaboutsupport.com/faq.html
I.P. Freely - 05 Mar 2008 00:42 GMT
> And if the hot peppers don't work, researchers at Kimmel Cancer center in
> Philadelphia have shown they can kill cancer cells by blocking a signaling
> protein that is key to the cancers growth called
> http://www.sciencedaily.com/releases/2008/02/080228080532.htm

And notice in the companion article at
http://www.sciencedaily.com/releases/2007/12/071231091452.htm :

"The researchers found [the signaling protein] Stat5 was active in 95
percent of these hormone resistant tumors, meaning it was more likely to
be active if the patient had been treated with hormone deprivation therapy.

Dr. Nevalainen shows that Stat5 interacts with the androgen receptors
and keeps them "transcriptionally active." Next, the scientists would
like to conduct tests in animal models to see if this synergy promotes
androgen-independent prostate tumor growth, and whether or not Stat5
synergizes with androgen receptors activated by adrenal androgens, which
are present in the absence of testicular androgens during the hormone
therapy of prostate cancer in patients.".

Just one more hypothetical gnat in the ADT debate.

I.P.
Alan Meyer - 05 Mar 2008 03:47 GMT
> ...
> And notice in the companion article at
[quoted text clipped - 17 lines]
>
> I.P.

These things are very difficult to interpret.  We need to ask the
researchers what they mean - assuming the researchers know.

Another way to read that article is that the expression of Stat5
is a part of the way that hormone refractory prostate cancer
cells become hormone refractory.  In other words hormone therapy
doesn't necessarily cause cancer cells to become more dangerous,
and doesn't cause them to express Stat5.  Rather perhaps it
causes selection of cells that express Stat5 by suppressing those
that don't.

In other words, hormone refractoriness and significant expression
of Stat5 may be two aspects of one phenomenon.

But again, although these issues raise critical research
questions, we still have to ask what is the primary measure of
interest when planning treatment?  I don't think it's the number
of molecules of Nestin or Stat5 in the cells that should
determine what treatment we should request, but the average
number of years of overall survival.

So far, to the best of my knowledge, early ADT is thought to
contribute to total overall survival time.  Whatever the
mechanisms are, this way or that, the balance of effect of early
ADT appears to be longer survival.

Maybe that's wrong.  Maybe the studies that claim that are
flawed.  It certainly turns out that way a lot in cancer
research.  But, so far, they are the best studies we have.

More and more, we're getting glimpses of what's really going on
in the cancer process.  But it's still the case that we have to
take our lives into our hands and leap into the unknown, playing
tricky odds where more cards on the table are concealed than
showing.

When someone like Gourd Dancer takes his leap and comes up a
winner, we are all thrilled and encouraged.  When one of us dies,
we bend our heads and wish him, and maybe a part of ourselves,
farewell.

  Alan
MikeHi@anon.co.uk - 06 Mar 2008 15:25 GMT
>> ...
>> And notice in the companion article at
>> http://www.sciencedaily.com/releases/2007/12/071231091452.htm:
>>/..snip snip snip

>> "The researchers found [the signaling protein] Stat5 was active
>> in 95 percent of these hormone resistant tumors, meaning it was
>> more likely to be active if the patient had been treated with
>> hormone deprivation therapy.
...../

>> Just one more hypothetical gnat in the ADT debate.
>>
>> I.P.

On Tue, 4 Mar 2008 19:47:48 -0800 (PST), Alan Meyer
<ameyer2@yahoo.com> wrote:/lots of snips

>So far, to the best of my knowledge, early ADT is thought to
>contribute to total overall survival time.  Whatever the
[quoted text clipped - 9 lines]
>
>   Alan

Hi all,

In dear old blighty we have a saying. 'After the Lord Mayor's
show...." (Explanation for our straw-chewing Colonial friends. The
Show includes lots of horses, all well fed...)
And hot on the heels of Nestin we have Stat5.
It's a classic case of 'what do we want first, the good news or the
bad'? This is how I sort it out - and welcome corrections.
    As always the bad news first. (And I agree, even that is based
only on early research.)
Hormone treatment opens up eventually two dangerous pathways for
metastasis - due to its encouragement of the Nestin and Stat5
proteins.  

Nestin is a "novel" pathway, just identified as found in cells only on
androgen withdrawal.  Knocking out Nestin in cells "diminished
Metastases 5-fold compared with controls".

Stat5 is a protein vital for the Pca cell to flourish. It is now found
to be turned on in nearly all recurrent prostate cancers that are
resistant to hormone therapy. "....convergence of Stat5 and androgen
receptor could be responsible for making such prostate cancers
especially dangerous."  (I note the use of the word, in a
scientifically controlled context, "especially").

    And now for....    The Good News   :
The detective work started, the scientists are calling out the hounds
on the trail of two very bad guys that nobody knew were even in the
neighbourhood!
The Stat2 study detectives, led by Marja Nevalainen, M.D., Ph.D.,
associate professor of Cancer Biology at Jefferson Medical College of
Thomas Jefferson University,
http://www.jefferson.edu/news/index.cfm?artid=2007/article15811.html
end with: "....proof of principle that Stat5 is a therapeutic target
protein for prostate cancer, and may be specifically useful for
advanced prostate cancer, where there are no effective therapies,.."
Next step in the work, Dr. Nevalainen says, "is to find
pharmacological agents that inhibit the protein."

And for Nestin, now its function is recognised in metastasis, the
scientists believe " it may lead to strategies to prevent and
neutralize metastatic spread."

Two new avenues for remedies!!

AND as I'm writing I've just spotted Ron's new post (Thanks Ron:
Blocking Protein Kills cancer cells) about a new molecule just created
to activate the p53 protein which can kill tumor cells. Other drugs
seeking to do the same job also cause normal cell damage. The new
protein, Ml-219 ..."...can be developed as a pill that patients could
take orally, rather than the traditional chemotherapy drugs that must
be given intravenously at a hospital or cancer center."

THREE more avenues for remedies!

So, yes, I'll certainly pause for a little more thought about hormone
treatment.

    And I can't work out the non-sequitur in all this. ADT creates
more deadly avenues for metastasis. But as Alan points out, ADT delays
mortality.  Answer? Have I none.

But my predominant reaction to all this stuff, is that the battle cry
should be more than ever - just hang on a bit lads - be in no doubt at
all -  the Pca cure is speeding towards us at exponential lightspeed!!

Still think that's not possible? Here's proof!:

There was a young lady of Wight,
Who travelled much faster than light,
She departed one day,
In a relative way,
And arrived on the previous night

(Thanks to Professor S.W. Hawking
http://www.hawking.org.uk/pdf/warp.pdf )

MikeHi
"Exponential lightspeed". Def: The discovery of the cure for Pca at a
speed which defies Einstein.
ronju99 - 06 Mar 2008 15:50 GMT
Hi Mike,
In spite of the potential benefits of the new MI-219 drug, the protein p53
can mutate and become ineffective. However, the protein p73 does not mutate
and apparently anticancer therapeutics targeting both pathways should
effect tumor cell
death.http://www.sciencedaily.com/releases/2007/03/070308220938.htm

Ron S.

--
Message posted using http://www.talkaboutsupport.com/group/alt.support.cancer.prostate/
More information at http://www.talkaboutsupport.com/faq.html
MikeHi@anon.co.uk - 06 Mar 2008 21:22 GMT
>Hi Mike,
>In spite of the potential benefits of the new MI-219 drug, the protein p53
[quoted text clipped - 4 lines]
>
>Ron S.

Hi Ron
Yep, thanks. So p73, cousin of p53 will do to kill tumors instead. I'd
settle for that! Clint's Magnum too!

Key phrase for me in that report is: "...targeting the p73-mediated
pathway of tumor cell death might provide a new avenue of research for
the development of anticancer therapeutics.

'New avenues'(p73) , 'new strategies' (Nestin), new 'therapeutic
target protein'(Stat5) - falling over each other in just a few days -
quite apart from what's already going on.

The race is well and truly on! And we're gonna be the winners! I'm
uplifted by the whole caboodle!
Mike
ronju99 - 06 Mar 2008 22:40 GMT
Mike,
This article is even more positive. Seeing how I go to Haley VA as a
veteran for treatment, I hope they can develop the Cardiac Hormones soon
for those that  especially have advance prostate cancer. I don't have
recurrent cancer yet but wouldn't be surprised if some time in the future
I would develop it because of my Gleason 7 .
http://www.sun-sentinel.com/features/health/sfl-fljjpscancer0304jjbnmar06,0,2866
25.story


Ron S.

--
Message posted using http://www.talkaboutsupport.com/group/alt.support.cancer.prostate/
More information at http://www.talkaboutsupport.com/faq.html

Rate this thread:






 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.